Ding, Jie
Zhang, Yushi
Wen, Jin
Zhang, Hui
Wang, Huiping
Luo, Yaping
Pan, Qingqing
Zhu, Wenjia
Wang, Xuezhu
Yao, Shaobo
Kreissl, Michael C.
Hacker, Marcus
Tong, Anli
Huo, Li http://orcid.org/0000-0003-1216-083X
Li, Xiang
Article History
Received: 5 December 2019
Accepted: 10 February 2020
First Online: 23 March 2020
Compliance with ethical standards
:
: SCINTOMICS owns the IP on Pentixafor. All other authors declare that they have no conflict of interest.
: The clinical institutional review board approved this study.